Robert E. Hoffman - Jun 1, 2023 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
President, CEO, and CFO, Director
Signature
/s/ Robert E. Hoffman
Stock symbol
KTRA
Transactions as of
Jun 1, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 04:05 PM
Previous filing
Aug 3, 2022
Next filing
Sep 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KTRA Common Stock, par value $0.001 per share Award $0 +59.8K +657% $0.00 68.9K Jun 1, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person was granted 59,800 restricted stock units, which will be settled in shares of the Issuer's common stock. The restricted stock units vest in full on June 1, 2024.